ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

Levothyroxine sodium Injection
Thyroid disease
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

Levothyroxine sodium Injection Rx

Generic Name and Formulations:
Levothyroxine sodium 100mcg, 200mcg, 500mcg; pwd for IV inj after reconstitution.

Company:
Various generic manufacturers

Therapeutic Use:

Indications for Levothyroxine sodium Injection:

Myxedema coma.

Limitations Of use:

Caution when converting from oral to intravenous levothyroxine.

Adult:

Individualize. Initially 300–500mcg IV once, then 50–100mcg IV once daily; switch to oral form and dose as soon as feasible. Elderly, underlying cardiovascular disease: may need lower doses.

Children:

Consult manufacturer.

Warnings/Precautions:

Not for treatment of obesity or weight loss. Adults: Monitor TSH 6–8 weeks after dose change then every 6–12 months. Peds: Monitor TSH 2 and 4 weeks after initiation, 2 weeks after dose change then every 3–12 months thereafter. Cardiovascular disease; monitor for cardiac arrhythmias during surgery. Reduce or withhold dose for 1 week if cardiac symptoms develop or worsen; restart at lower dose. Tabs: not for treating myxedema coma. Correct adrenal insufficiency before initiation. Increased sensitivity in severe hypothyroidism. Diabetes; monitor glucose control. Use lowest effective dose. Elderly. Pregnancy: monitor TSH at least every trimester; adjust dose and do not discontinue (see full labeling). Nursing mothers.

Interactions:

See full labeling. Absorption reduced by some foods (eg, soy flour, cottonseed meal, walnuts, fiber, grapefruit juice), aluminum and magnesium hydroxide, simethicone, proton pump inhibitors, iron, sucralfate; monitor. Give at least 4hrs apart from calcium carbonate, ferrous sulfate, bile acid sequestrants (eg, colesevelam, cholestyramine, colestipol), ion exchange resins (eg, kayexalate, sevelamer). Potentiates, and is potentiated by, tri- and tetracyclic antidepressants. Concomitant sympathomimetics; monitor for coronary insufficiency. Antagonized by phenobarbital, rifampin, sertraline. Antagonizes digitalis glycosides. Marked hypertension and tachycardia with ketamine. Hypothyroidism risk with concomitant tyrosine kinase inhibitors (eg, imatinib). Estrogens, androgens, corticosteroids affect thyroid function tests. Monitor oral anticoagulants, antidiabetic agents, orlistat.

See Also:

SYNTHROID

Pharmacological Class:

T4 (synthetic).

Adverse Reactions:

Arrhythmias, myocardial infarction, dyspnea, muscle spasm, headache, nervousness, irritability, insomnia, tremors, muscle weakness, increased appetite, weight loss, diarrhea, heat intolerance, menstrual irregularities, skin rash; seizures (rare); Children: pseudotumor cerebri, slipped capital femoral epiphysis.

Generic Availability:

YES

How Supplied:

Tabs (all)—90, 1000; Tabs (25mcg, 50mcg, 75mcg, 88mcg, 100mcg, 125mcg, 175mcg)—100; Single-use vials—1

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs